Bank Of New York Mellon Corp Abbott Laboratories Transaction History
Bank Of New York Mellon Corp
- $538 Trillion
- Q3 2024
A detailed history of Bank Of New York Mellon Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 13,562,399 shares of ABT stock, worth $1.55 Billion. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,562,399
Previous 14,155,518
4.19%
Holding current value
$1.55 Billion
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.2 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.76 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.51 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.09 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...